In an incredibly sunny London, our CTO Giuseppe Roscilli had the pleasure to present our innovative approaches for generating and producing monoclonal antibodies at the Antibody and Engineering Therapeutics Congress.
Utilizing #technologies like DNA-EGT, we efficiently produce high-quality antibodies, surpassing the limitations of conventional methods. Our high-throughput techniques for screening antibody phenotypes and antigen specificity from primary B cells provide a cost-effective and efficient platform for identifying antigen-specific antibodies from human and mouse B cells. These advancements are combined with high-troughput antibody production and purification, […]